Diaceutics EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access Premium The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments. LGC SeraCare Joins Diaceutics DXRX Network for Precision Medicine Diagnostics The partnership will introduce additional types of test reference materials to users of the platform, including the Seraseq FFPE Tumor Fusion RNA Reference Material v4. Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care. Diaceutics Developing New Platform to Improve Access to Precision Medicine Premium The DXRX marketplace, planned for launch in the fourth quarter of 2020, will provide a way for pharmaceutical companies, diagnostic firms, and laboratories to collaborate. Amid COVID-19, Lower Cancer Diagnosis Rates Mean Fewer Patients Getting Molecular Tests, Treatment Premium Data amassed by analytics firm Diaceutics suggests fewer patients are coming into healthcare facilities and missing the chance for diagnosis, molecular testing, and treatment. Apr 19, 2020 Despite FDA Guidance, CDx Providers Still Have Challenges in Seeking 'Therapeutic Group' Indication Premium Oct 22, 2019 Report Says Many Precision Drugs Will Launch in Coming Years But Unclear if They Will Reach Patients Premium Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Feb 4, 2019 Delayed Testing, Limited Patient Understanding May Hinder Precision Oncology Access, Survey Suggests Premium May 22, 2017 Cancer Patients Missing Personalized Therapy Due to Quality Issues for Genetic Tests Apr 24, 2017 Diaceutics Inks Deal for BioReference Labs Dx Data Feb 28, 2017 Q&A: Labceutics' Jordan Clark on Industry, FDA Gap on Rx/Dx Codevelopment Principles Premium Jan 9, 2017 In 2016, Personalized Medicine Saw More CDx Deals, Flexible FDA, No LDT Guidance Premium Feb 1, 2016 New Complementary Dx Category Provides Regulatory Flexibility, but Poses Real World Challenges Premium May 28, 2015 ARUP, Labceutics Partner to Provide Lab Services to Personalized Drug Developers Nov 12, 2014 Report Finds More Personalized Rx on the Market, but Field Lacks 'Integrator' Premium Mar 19, 2014 Amid Regulatory and Reimbursement Difficulties, Some Encouraging Advancements for Personalized Rx Premium Mar 12, 2014 Pharma Slowly Adapting to Complexities and Challenges of Developing Personalized Medicine Premium Dec 18, 2013 People in the News: Peter Kim, Julie Goonewardene, Walter Capone Premium Dec 11, 2013 MDx/CDx Focus: Diaceutics, CAHG Launch Bioceutics; LabCorp Submits IDE for Gencaro CDx Premium Mar 13, 2013 Labceutics, Asuragen Conducting BCR-ABL Quality Assurance Study Among European Labs Premium Dec 12, 2012 With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option Premium Nov 2, 2012 Dx Assays Launches Fee-for-Service CDx Development Initiative Giving Pharma More Control Premium Jun 27, 2012 MDx/CDx Focus: Cellceutix Planning Phase I Study for Kevetrin; Labceutics Launches EU Lab Network Premium Mar 14, 2012 Survey Finds Pharma Needs to Strategically Engage EU Labs when Launching Personalized Rx Products Premium Load More Breaking News UBS Initiates Coverage of 10X Genomics, PacBio, Akoya Biosciences, NanoString Technologies Circadian Gene Expression Variation Across Tissue Types May Offer Aging, Disease Clues Siemens Healthineers Q1 Dx Revenues Fall 21 Percent; Firm Strikes Lab Analyzer Deal With Unilabs Becton Dickinson Fiscal Q1 Revenues Down 3 Percent; Firm Raises FY23 Guidance NanoString Technologies, Weill Cornell Medicine Collaborate on Spatial Atlas of Human Tissues The Scan White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans. Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients. Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study. Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.